1-16 of 16
Eric McLaughlin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Results of a Phase 2 Study of Venetoclax Added to Ibrutinib to Eliminate Ibrutinib Resistance Mutations in CLL

Kerry A Rogers, Eric McLaughlin, Lai Wei, Seema A Bhat, Arianna Crouse, Michael R. Grever, Dan Jones, Adam S Kittai, Gerard Lozanski, Mollie Moran, Mark Reid, Ellen J Sass, Swetha Suresh, John C. Byrd, Jennifer A. Woyach
Journal: Blood
Blood (2023) 142 (Supplement 1): 1899.
https://doi.org/10.1182/blood-2023-180294
Published: 2023
Journal Articles

Treatment Patterns and Outcomes for Patients with Classic Hodgkin Lymphoma (cHL) and Cardiomyopathy with Low Ejection Fraction (EF): Real-World Evidence (RWE) from 16 US Academic Centers

Kaitlin Annunzio, Eric McLaughlin, Timothy Voorhees, Lauren Kelly Shea, Nuttavut Sumransub, Ashley Rose, Adam J Olszewski, Neil Bailey, Krish Patel, Tamara K. Moyo, Farrukh T. Awan, Gulrayz Ahmed, Natalie S. Grover, Adam Adika, Erica L Andres, Muhammad Salman Faisal, Beth Christian, Jacob Anna, Steven M. Bair, Nicholas Kendsersky, Colin Thomas, Pallawi Torka, Jakub Svoboda, Jordan S Carter, Mehdi Hamadani, Hayder Saeed, Sanjal H. Desai, Andrew M Evens, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 382.
https://doi.org/10.1182/blood-2023-182389
Published: 2023
Journal Articles

Gemcitabine and Liposomal Doxorubicin (GemDox) for the Treatment of Relapsed and Refractory T-Cell Lymphomas

Zachary Braunstein, Allyson Waller, Emily Dotson, Eric McLaughlin, Walter Hanel, John C Reneau, Daniel Addison, Pierluigi Porcu, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4453.
https://doi.org/10.1182/blood-2023-184583
Published: 2023
Journal Articles

Post-Allograft Romidepsin Maintenance Mitigates Relapse Risk and Stimulates the Graft-Versus-Malignancy Effect through Enhanced NK-Cell Cytotoxicity in Patients with T-Cell Malignancies: Final Results of a Phase I/II Trial

Chitra Hosing, Zachary Braunstein, Eric McLaughlin, Benigno C. Valdez, Borje S. Andersson, Uday R. Popat, Sumithira Vasu, Evandro Bezzera, Gabriela Sanchez-Petitto, Sarah A Wall, Samantha M. Jaglowski, Sam Penza, Hannah Choe, Lai Wei, Robin Nakkula, Alex Cash, Richard E. Champlin, Marcos de Lima, Steven M. Devine, Dean Anthony Lee, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 184.
https://doi.org/10.1182/blood-2023-190213
Published: 2023
Journal Articles

Allogeneic Stem Cell Transplant and CD30 Directed CART Cell Therapies Are Associated with Improved Survival in Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers

Timothy Voorhees, Natalie S. Grover, Eric McLaughlin, Jorge A Florindez, Tamara K. Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish R. Ayyappan, Lauren Kelly Shea, Matthew J Cortese, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal H. Desai, Praveen Ramakrishnan Geethakumari, Pallawi Torka, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 900.
https://doi.org/10.1182/blood-2023-182385
Published: 2023
Journal Articles

Real-World Evaluation of T-Prolymphocytic Leukemia Outcomes Using the 2019 T-PLL International Study Group Criteria

Zachary Braunstein, Eric McLaughlin, Anjali Mishra, Pierluigi Porcu, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 6213.
https://doi.org/10.1182/blood-2023-184602
Published: 2023
Journal Articles

Outcomes in Patients with Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers

Timothy Voorhees, Eric McLaughlin, Pallawi Torka, Jorge A Florindez, Tamara K. Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish R. Ayyappan, Lauren Kelly Shea, Matthew J Cortese, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal H. Desai, Praveen Ramakrishnan Geethakumari, Natalie S. Grover, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 3061.
https://doi.org/10.1182/blood-2023-181056
Published: 2023
Journal Articles

Extended Follow up of a Phase 2 Study of Ibrutinib in Hairy Cell Leukemia

Kerry A. Rogers, Eric McLaughlin, Lai Wei, Mirela Iulia Anghelina, Mir Khader Ali, Leslie A. Andritsos, Evgeny Arons, James S. Blachly, Timothy G. Call, S. Percy Ivy, Lacey James-Echenique, Jeffrey A. Jones, Robert J. Kreitman, Gerard Lozanski, Farhad Ravandi, Charles A. Schiffer, William E. Carson, III, Michael R. Grever
Journal: Blood
Blood (2022) 140 (Supplement 1): 6494–6495.
https://doi.org/10.1182/blood-2022-165795
Published: 2022
Journal Articles

Post-Allograft Romidepsin Maintenance Mitigates Relapse Risk and Stimulates the Graft-Versus-Malignancy Effect through Enhanced NK-Cell Cytotoxicity in Patients with Aggressive T-Cell Malignancies in a Phase I/II Trial

Chitra Hosing, Eric McLaughlin, Zachary Braunstein, Benigno C Valdez, Lai Wei, Uday R Popat, Borje S Andersson, Sumithira Vasu, Karilyn T. Larkin, Samantha Jaglowski, Sam Penza, Ayman Saad, Hannah Choe, Sarah A Wall, Alex Cash, Robin Nakkula, Richard E Champlin, Marcos J.G. de Lima, Dean Anthony Lee, Jonathan E Brammer
Journal: Blood
Blood (2022) 140 (Supplement 1): 1885–1886.
https://doi.org/10.1182/blood-2022-169336
Published: 2022
Journal Articles

Impact of Circulating Lymphoma at Diagnosis on Outcomes in Patients with Diffuse Large B-Cell Lymphoma

Srichandhana Rajamouli, Eric McLaughlin, Walter Hanel, David A. Bond, Yazeed Sawalha, Timothy J. Voorhees, Lapo Alinari, Lalit Sehgal, Kami J. Maddocks, Beth Christian, Daniel Jones, Narendranath Epperla
Journal: Blood
Blood (2022) 140 (Supplement 1): 6659–6660.
https://doi.org/10.1182/blood-2022-166988
Published: 2022
Journal Articles

Romidepsin in Conditioning and Maintenance Mitigates Relapse Risk and Enhances NK-Cell Cytotoxicity in Patients Receiving Allogeneic Stem Cell Transplant for Aggressive T-Cell Malignancies: Results of a Phase I/II Clinical Trial

Chitra Hosing, Zachary Braunstein, Alaa M Ali, Benigno C. Valdez, Borje S. Andersson, Uday R. Popat, Sumithira Vasu, Karilyn Larkin, Sam Penza, Hannah Choe, Ayman Saad, Marcos J.G. de Lima, Lai Wei, Eric McLaughlin, Robin Nakkula, Amanda Campbell, Prashant Trikha, Marcin Puto, Basem M. William, Richard E. Champlin, Dean Anthony Lee, Jonathan E Brammer
Journal: Blood
Blood (2021) 138 (Supplement 1): 553.
https://doi.org/10.1182/blood-2021-152833
Published: 2021
Journal Articles

Survival Analysis of Patients with T-Cell Lymphoma or T-Cell Large Granular Leukemia and Concomitant Plasma Cell Dyscrasias

Zachary Braunstein, Miguel Ruiz, Eric McLaughlin, Naresh Bumma, Don M Benson, Jr., Srinivas Devarakonda, Maria Chaudhry, Abdullah Khan, Francesca Cottini, John C. Reneau, Pierluigi Porcu, Anjali Mishra, Ashley E. Rosko, Jonathan E Brammer
Journal: Blood
Blood (2021) 138 (Supplement 1): 2449.
https://doi.org/10.1182/blood-2021-152556
Published: 2021
Journal Articles

Cyclophosphamide Induces Durable Molecular and Clinical Responses in Patients with Relapsed T-Large Granular Lymphocytic Leukemia (T-LGLL)

Zachary Braunstein, Eric McLaughlin, Anjali Mishra, Jonathan E Brammer
Journal: Blood
Blood (2021) 138 (Supplement 1): 2471.
https://doi.org/10.1182/blood-2021-147624
Published: 2021
Journal Articles

Final Results of a Phase 2 Trial of Early Intervention Ibrutinib with Vaccinations in Patients with Asymptomatic, High-Risk CLL

Jennifer Woyach, MD, Shanmugapriya Thangavadivel, PhD, David Weiss, Lai Wei, PhD, Eric McLaughlin, MS, Kerry Rogers, Seema A. Bhat, MD, Michael R. Grever, MD, Michael Keller, Matthew Dort, Gerard Lozanski, MD, Barbara Andersen, PhD, John C. Byrd, MD, Farrukh T. Awan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1759.
https://doi.org/10.1182/blood-2019-131099
Published: 2019
Journal Articles

Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803/AMC-071 Trials

Polina Shindiapina, MD PhD, Maciej Pietrzak, PhD, Michal Seweryn, PhD, Eric McLaughlin, MS, Xiaoli Zhang, PhD, Mateusz Makowski, PhD, Justin Lyberger, Hsiaochi Chang, Elshafa Hassan Ahmed, DVM, PhD, Alexander Prouty, BS, Rebecca Pearson, Rhonda Kitzler, Jennifer Le-Rademacher, PhD, Richard F. Little, MD MPH, Gorgun Akpek, MD, Ernesto Ayala, MD, Steven Devine, MD, Ariela Noy, MD, Lawrence D Kaplan, MD, Uday Popat, MD, Jack W. Hsu, MD, Lawrence E Morris, MD, Adam M. Mendizabal, MS, Craig C Hofmeister, MDMPH, William Wachsman, MD PhD, Stephen J Forman, MD, Willis H. Navarro, MD, Joseph C. Alvarnas, MD, Richard F. Ambinder, MD, Gregory K. Behbehani, MD PhD, Gerard Lozanski, MD, Robert A Baiocchi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4525.
https://doi.org/10.1182/blood-2019-129488
Published: 2019
Journal Articles

Enhanced Spontaneous Anti-Tumor Cytotoxicity of Natural Killer Cells in Cutaneous T-Cell Lymphoma Patients

Bethany L Mundy-Bosse, PhD, Nathan Denlinger, MS, DO, Susan Huang, MD, Li Chen, Hsiaoyin Mao, David Kline, Eric McLaughlin, Youssef Youssef, Karen Young, Gerard Lozanski, MD, Aharon G. Freud, MD PhD, Pierluigi Porcu, MD, Basem M. William, MD, Michael A. Caligiuri, MD, Anjali Mishra, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2753.
https://doi.org/10.1182/blood.V130.Suppl_1.2753.2753
Published: 2017